US Stock MarketDetailed Quotes

HUM Humana

Watchlist
  • 259.760
  • -6.000-2.26%
Close Mar 7 16:00 ET
  • 260.000
  • +0.240+0.09%
Post 20:01 ET
31.34BMarket Cap26.03P/E (TTM)

About Humana Company

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Company Profile

SymbolHUM
Company NameHumana
Listing DateMay 18, 1971
Founded1961
CEOMr. James A. Rechtin
MarketNYSE
Employees65680
Fiscal Year Ends12-31
Address500 West Main Street
CityLouisville
ProvinceKentucky
CountryUnited States of America
Zip Code40202
Phone1-502-580-1000

Company Executives

  • Name
  • Position
  • Salary
  • James A. Rechtin
  • Director, President and Chief Executive Officer
  • --
  • Michelle A. O’Hara
  • Chief Human Resources Officer
  • --
  • Vishal Agrawal
  • Chief Strategy and Corporate Development Officer
  • --
  • Joseph C. Ventura
  • Chief Legal Officer
  • 3.10M
  • John-Paul W. Felter
  • Senior Vice President, Chief Accounting Officer and Controller
  • --
  • Japan A. Mehta
  • Chief Information Officer
  • --
  • Celeste M. Mellet
  • Chief Financial Officer
  • --
  • Dr. Sanjay K. Shetty, M.D.
  • President, CenterWell
  • 4.58M
  • David E. Dintenfass
  • President, Enterprise Growth
  • --
  • George Renaudin, II
  • President, Insurance
  • 3.05M
  • Kurt J. Hilzinger
  • Chairman of the Board
  • 601.30K
  • John W. Garratt
  • Independent Director
  • 326.03K
  • Brad D. Smith
  • Independent Director
  • 311.07K
  • Dr. Wayne A.I. Frederick, M.D.
  • Independent Director
  • 364.87K
  • Jorge S. Mesquita
  • Independent Director
  • 351.59K
  • Karen W. Katz
  • Independent Director
  • 219.97K
  • Marcy S. Klevorn
  • Independent Director
  • 351.94K
  • Dr. Raquel C. Bono, M.D.
  • Independent Director
  • 345.03K
  • Gordon A. Smith
  • Independent Director
  • --
  • Frank A. D'Amelio
  • Independent Director
  • 363.55K
  • Dr. David T. Feinberg, M.D.,PhD
  • Independent Director
  • 321.52K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More